Archive: 15. 4. 1990, Volume: 3, Issue: 2

Klin Onkol 1990; 3(2): 35-37.
Authors: Němec Jaroslav1990-04-15:Iphosphamid

Klin Onkol 1990; 3(2): 38-40.
Authors: Kopečný J.1990-04-15:Ethiological factors in ovarian carcinomas

Klin Onkol 1990; 3(2): 41-43.
Authors: Eckschlager Tomáš, Koutecký Josef1990-04-15:Suprarenal gland carcinomas in children

Klin Onkol 1990; 3(2): 44-49.
Authors: Žaloudík Jan, Rejthar Aleš, Mechl Zdeněk, Ghosh A.K.1990-04-15:HLA-D antigens and the progress of malignant melanoma

Klin Onkol 1990; 3(2): 50-52.
Authors: Munzarová M., Kovařík Jan, Pačovský Zdeněk, Lorenz Ivan1990-04-15:Non-specific active immunotherapy with the BCG vaccine in patients with breast carcinoma. Evaluation after 7 year follow-up

Klin Onkol 1990; 3(2): 53-55.
Authors: Šmérková N., Nekulová Miroslava, Šakalová J.1990-04-15:The follow up of alfa1-antitrypsin concentration, alfa1-acid glykoprotein and prealbumin in patients with malignant breast cancer

Klin Onkol 1990; 3(2): 56-58.
Authors: Sieghart S.1990-04-15:Clinical experiences with Clodronate

Klin Onkol 1990; 3(2): 58-60.
Authors: Mechl Zdeněk1990-04-15:Anandron

Klin Onkol 1990; 3(2): 60.
Authors: Giona F., Testi A.M., Amadori S.1990-04-15:Idarubicin and high-dose cytarabine in the treatment of refractory and relapsed acute lymphoblastic leukemia

Klin Onkol 1990; 3(2): 60-61.
Authors: Cummings B.J.1990-04-15:The treatment of anal carcinoma

Klin Onkol 1990; 3(2): 61.
Authors: Hiddemann Wolfgang, Kreutzmann H., Donhuijsen-Ant R.1990-04-15:High dose cytosine-arabinoside and mitoxantrone (HAM) for the treatment of refractory acute lymphoblastic leukemia